APRE
Closed
Aprea Therapeutics Inc
1.65
-0.04 (-2.37%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.69
Day's Range: 1.6412 - 1.72
Send
sign up or login to leave a comment!
When Written:
4.44
Aprea Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing novel cancer therapeutics. The company's lead drug candidate, eprenetapopt (APR-246), is currently in clinical trials for the treatment of hematologic malignancies and solid tumors. Aprea Therapeutics also has a pipeline of other small molecule drugs that target p53, a tumor suppressor protein that is mutated in many types of cancer. The company was founded in 2003 and is headquartered in Boston, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








